Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer
<p>Abstract</p> <p>Background</p> <p>In recent years, numerous studies have investigated somatic mutations in mitochondrial DNA in various tumours. The observed high mutation rates might reflect mitochondrial deregulation; consequently, mutation analyses could be clinic...
Main Authors: | Rachinger Andrea, Bartnik Ewa, Kupryjanczyk Jolanta, Bragoszewski Piotr, Ostrowski Jerzy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-10-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/8/292 |
Similar Items
-
Control of mitochondrial biogenesis and function by the ubiquitin–proteasome system
by: Piotr Bragoszewski, et al.
Published: (2017-01-01) -
The mutational analysis of mitochondrial DNA in maternal inheritance of polycystic ovarian syndrome
by: Shaheen Bibi, et al.
Published: (2023-08-01) -
Cytosolic Quality Control of Mitochondrial Protein Precursors—The Early Stages of the Organelle Biogenesis
by: Anna M. Lenkiewicz, et al.
Published: (2021-12-01) -
Metastatic pattern of ovarian cancer delineated by tracing the evolution of mitochondrial DNA mutations
by: Zhiyang Xu, et al.
Published: (2023-07-01) -
Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer
by: Katarzyna Aleksandra Kujawa, et al.
Published: (2020-01-01)